Europe Percutaneous Transluminal Angioplasty Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Percutaneous Transluminal Angioplasty market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 13.2% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Percutaneous Transluminal Angioplasty Market Segmentations:

    By Player:

    • Jarvix Heart

    • InspireMD

    • Defibtech

    • Berlin Heart

    • Shimadzu

    • Carmat

    • Impulse Dynamics

    • Heartware International

    • OrbusNeich

    • CorMatrix Cardiovascular

    • Advanced Cardiac Therapeutics

    • AtriCure

    • Biotronik

    • Edwards Lifesciences

    • Omron

    • REVA Medical

    • Endologix

    • Opto Circuits (India)

    • Philips Healthcare

    • SMT

    • Volcano

    • Stereotaxis

    • Abbott Laboratories

    • Deltex Medical

    • Elixir Medical

    • Cordis

    • SeptRx

    • Biosensors International

    • Hexacath

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • Medical care

    • Hospital

    • Laboratory

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Percutaneous Transluminal Angioplasty Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Percutaneous Transluminal Angioplasty Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Percutaneous Transluminal Angioplasty Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Percutaneous Transluminal Angioplasty Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Percutaneous Transluminal Angioplasty Market Size and Growth Rate of Medical care from 2014 to 2026

    • 1.4.2 Europe Percutaneous Transluminal Angioplasty Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.3 Europe Percutaneous Transluminal Angioplasty Market Size and Growth Rate of Laboratory from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Percutaneous Transluminal Angioplasty Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Percutaneous Transluminal Angioplasty by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Percutaneous Transluminal Angioplasty Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Percutaneous Transluminal Angioplasty by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Percutaneous Transluminal Angioplasty for Medical care

      • 4.4.2 Market Size and Growth Rate of Percutaneous Transluminal Angioplasty for Hospital

      • 4.4.3 Market Size and Growth Rate of Percutaneous Transluminal Angioplasty for Laboratory

    5 Market Analysis by Major Regions

    • 5.1 Europe Percutaneous Transluminal Angioplasty Production Analysis by Top Regions

    • 5.2 Europe Percutaneous Transluminal Angioplasty Consumption Analysis by Top Regions

    • 5.3 Europe Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

      • 5.3.3 France Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    6 Product Circulation of Percutaneous Transluminal Angioplasty Market among Top Countries

    • 6.1 Top 5 Export Countries in Percutaneous Transluminal Angioplasty Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Percutaneous Transluminal Angioplasty Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Percutaneous Transluminal Angioplasty Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Percutaneous Transluminal Angioplasty Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Percutaneous Transluminal Angioplasty Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Percutaneous Transluminal Angioplasty Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Percutaneous Transluminal Angioplasty Landscape Analysis

    • 7.1 Germany Percutaneous Transluminal Angioplasty Landscape Analysis by Major Types

    • 7.2 Germany Percutaneous Transluminal Angioplasty Landscape Analysis by Major End-Users

    8. UK Percutaneous Transluminal Angioplasty Landscape Analysis

    • 8.1 UK Percutaneous Transluminal Angioplasty Landscape Analysis by Major Types

    • 8.2 UK Percutaneous Transluminal Angioplasty Landscape Analysis by Major End-Users

    9. France Percutaneous Transluminal Angioplasty Landscape Analysis

    • 9.1 France Percutaneous Transluminal Angioplasty Landscape Analysis by Major Types

    • 9.2 France Percutaneous Transluminal Angioplasty Landscape Analysis by Major End-Users

    10. Italy Percutaneous Transluminal Angioplasty Landscape Analysis

    • 10.1 Italy Percutaneous Transluminal Angioplasty Landscape Analysis by Major Types

    • 10.2 Italy Percutaneous Transluminal Angioplasty Landscape Analysis by Major End-Users

    11. Spain Percutaneous Transluminal Angioplasty Landscape Analysis

    • 11.1 Spain Percutaneous Transluminal Angioplasty Landscape Analysis by Major Types

    • 11.2 Spain Percutaneous Transluminal Angioplasty Landscape Analysis by Major End-Users

    12. Poland Percutaneous Transluminal Angioplasty Landscape Analysis

    • 12.1 Poland Percutaneous Transluminal Angioplasty Landscape Analysis by Major Types

    • 12.2 Poland Percutaneous Transluminal Angioplasty Landscape Analysis by Major End-Users

    13. Russia Percutaneous Transluminal Angioplasty Landscape Analysis

    • 13.1 Russia Percutaneous Transluminal Angioplasty Landscape Analysis by Major Types

    • 13.2 Russia Percutaneous Transluminal Angioplasty Landscape Analysis by Major End-Users

    14. Switzerland Percutaneous Transluminal Angioplasty Landscape Analysis

    • 14.1 Switzerland Percutaneous Transluminal Angioplasty Landscape Analysis by Major Types

    • 14.2 Switzerland Percutaneous Transluminal Angioplasty Landscape Analysis by Major End-Users

    15. Turkey Percutaneous Transluminal Angioplasty Landscape Analysis

    • 15.1 Turkey Percutaneous Transluminal Angioplasty Landscape Analysis by Major Types

    • 15.2 Turkey Percutaneous Transluminal Angioplasty Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Landscape Analysis by Top Countries

      • 16.3.1 Denmark Percutaneous Transluminal Angioplasty Market Volume and Growth Rate

      • 16.3.2 Finland Percutaneous Transluminal Angioplasty Market Volume and Growth Rate

      • 16.3.3 Norway Percutaneous Transluminal Angioplasty Market Volume and Growth Rate

      • 16.3.4 Sweden Percutaneous Transluminal Angioplasty Market Volume and Growth Rate

      • 16.3.6 Iceland Percutaneous Transluminal Angioplasty Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Landscape Analysis by Top Countries

      • 17.3.1 Belgium Percutaneous Transluminal Angioplasty Market Volume and Growth Rate

      • 17.3.2 Netherlands Percutaneous Transluminal Angioplasty Market Volume and Growth Rate

      • 17.3.3 Luxembourg Percutaneous Transluminal Angioplasty Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Landscape Analysis by Top Countries

      • 18.3.1 Estonia Percutaneous Transluminal Angioplasty Market Volume and Growth Rate

      • 18.3.2 Latvia Percutaneous Transluminal Angioplasty Market Volume and Growth Rate

      • 18.3.3 Lithuania Percutaneous Transluminal Angioplasty Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Jarvix Heart

      • 19.1.1 Jarvix Heart Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 InspireMD

      • 19.2.1 InspireMD Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Defibtech

      • 19.3.1 Defibtech Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Berlin Heart

      • 19.4.1 Berlin Heart Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Shimadzu

      • 19.5.1 Shimadzu Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Carmat

      • 19.6.1 Carmat Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Impulse Dynamics

      • 19.7.1 Impulse Dynamics Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Heartware International

      • 19.8.1 Heartware International Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 OrbusNeich

      • 19.9.1 OrbusNeich Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 CorMatrix Cardiovascular

      • 19.10.1 CorMatrix Cardiovascular Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Advanced Cardiac Therapeutics

      • 19.11.1 Advanced Cardiac Therapeutics Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 AtriCure

      • 19.12.1 AtriCure Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Biotronik

      • 19.13.1 Biotronik Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Edwards Lifesciences

      • 19.14.1 Edwards Lifesciences Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Omron

      • 19.15.1 Omron Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 REVA Medical

      • 19.16.1 REVA Medical Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Endologix

      • 19.17.1 Endologix Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Opto Circuits (India)

      • 19.18.1 Opto Circuits (India) Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Philips Healthcare

      • 19.19.1 Philips Healthcare Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 SMT

      • 19.20.1 SMT Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Volcano

      • 19.21.1 Volcano Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Stereotaxis

      • 19.22.1 Stereotaxis Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Abbott Laboratories

      • 19.23.1 Abbott Laboratories Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Deltex Medical

      • 19.24.1 Deltex Medical Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    • 19.25 Elixir Medical

      • 19.25.1 Elixir Medical Company Profile and Development Status

      • 19.25.2 Market Performance

      • 19.25.3 Product and Service Introduction

    • 19.26 Cordis

      • 19.26.1 Cordis Company Profile and Development Status

      • 19.26.2 Market Performance

      • 19.26.3 Product and Service Introduction

    • 19.27 SeptRx

      • 19.27.1 SeptRx Company Profile and Development Status

      • 19.27.2 Market Performance

      • 19.27.3 Product and Service Introduction

    • 19.28 Biosensors International

      • 19.28.1 Biosensors International Company Profile and Development Status

      • 19.28.2 Market Performance

      • 19.28.3 Product and Service Introduction

    • 19.29 Hexacath

      • 19.29.1 Hexacath Company Profile and Development Status

      • 19.29.2 Market Performance

      • 19.29.3 Product and Service Introduction

    The List of Tables and Figures (Totals 80 Figures and 150 Tables)

    • Figure Product Picture

    • Figure Europe Percutaneous Transluminal Angioplasty Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Percutaneous Transluminal Angioplasty Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Percutaneous Transluminal Angioplasty Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Percutaneous Transluminal Angioplasty Market Size and Growth Rate of Medical care from 2014 to 2026

    • Figure Europe Percutaneous Transluminal Angioplasty Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Europe Percutaneous Transluminal Angioplasty Market Size and Growth Rate of Laboratory from 2014 to 2026

    • Figure Germany Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure UK Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure France Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Percutaneous Transluminal Angioplasty Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Percutaneous Transluminal Angioplasty Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Percutaneous Transluminal Angioplasty

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Percutaneous Transluminal Angioplasty by Different Types from 2014 to 2026

    • Table Consumption Share of Percutaneous Transluminal Angioplasty by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Percutaneous Transluminal Angioplasty by Different End-Users from 2014 to 2026

    • Table Consumption Share of Percutaneous Transluminal Angioplasty by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Medical care

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Laboratory

    • Table Europe Percutaneous Transluminal Angioplasty Production by Major Regions

    • Table Europe Percutaneous Transluminal Angioplasty Production Share by Major Regions

    • Figure Europe Percutaneous Transluminal Angioplasty Production Share by Major Countries and Regions in 2014

    • Table Europe Percutaneous Transluminal Angioplasty Consumption by Major Regions

    • Table Europe Percutaneous Transluminal Angioplasty Consumption Share by Major Regions

    • Table Germany Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    • Table UK Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    • Table France Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    • Table Italy Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    • Table Spain Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    • Table Poland Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    • Table Russia Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    • Table Switzerland Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    • Table Turkey Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Percutaneous Transluminal Angioplasty Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Percutaneous Transluminal Angioplasty Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Percutaneous Transluminal Angioplasty Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Percutaneous Transluminal Angioplasty Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Percutaneous Transluminal Angioplasty Consumption by Types from 2014 to 2026

    • Table Germany Percutaneous Transluminal Angioplasty Consumption Share by Types from 2014 to 2026

    • Table Germany Percutaneous Transluminal Angioplasty Consumption by End-Users from 2014 to 2026

    • Table Germany Percutaneous Transluminal Angioplasty Consumption Share by End-Users from 2014 to 2026

    • Table UK Percutaneous Transluminal Angioplasty Consumption by Types from 2014 to 2026

    • Table UK Percutaneous Transluminal Angioplasty Consumption Share by Types from 2014 to 2026

    • Table UK Percutaneous Transluminal Angioplasty Consumption by End-Users from 2014 to 2026

    • Table UK Percutaneous Transluminal Angioplasty Consumption Share by End-Users from 2014 to 2026

    • Table France Percutaneous Transluminal Angioplasty Consumption by Types from 2014 to 2026

    • Table France Percutaneous Transluminal Angioplasty Consumption Share by Types from 2014 to 2026

    • Table France Percutaneous Transluminal Angioplasty Consumption by End-Users from 2014 to 2026

    • Table France Percutaneous Transluminal Angioplasty Consumption Share by End-Users from 2014 to 2026

    • Table Italy Percutaneous Transluminal Angioplasty Consumption by Types from 2014 to 2026

    • Table Italy Percutaneous Transluminal Angioplasty Consumption Share by Types from 2014 to 2026

    • Table Italy Percutaneous Transluminal Angioplasty Consumption by End-Users from 2014 to 2026

    • Table Italy Percutaneous Transluminal Angioplasty Consumption Share by End-Users from 2014 to 2026

    • Table Spain Percutaneous Transluminal Angioplasty Consumption by Types from 2014 to 2026

    • Table Spain Percutaneous Transluminal Angioplasty Consumption Share by Types from 2014 to 2026

    • Table Spain Percutaneous Transluminal Angioplasty Consumption by End-Users from 2014 to 2026

    • Table Spain Percutaneous Transluminal Angioplasty Consumption Share by End-Users from 2014 to 2026

    • Table Poland Percutaneous Transluminal Angioplasty Consumption by Types from 2014 to 2026

    • Table Poland Percutaneous Transluminal Angioplasty Consumption Share by Types from 2014 to 2026

    • Table Poland Percutaneous Transluminal Angioplasty Consumption by End-Users from 2014 to 2026

    • Table Poland Percutaneous Transluminal Angioplasty Consumption Share by End-Users from 2014 to 2026

    • Table Russia Percutaneous Transluminal Angioplasty Consumption by Types from 2014 to 2026

    • Table Russia Percutaneous Transluminal Angioplasty Consumption Share by Types from 2014 to 2026

    • Table Russia Percutaneous Transluminal Angioplasty Consumption by End-Users from 2014 to 2026

    • Table Russia Percutaneous Transluminal Angioplasty Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Percutaneous Transluminal Angioplasty Consumption by Types from 2014 to 2026

    • Table Switzerland Percutaneous Transluminal Angioplasty Consumption Share by Types from 2014 to 2026

    • Table Switzerland Percutaneous Transluminal Angioplasty Consumption by End-Users from 2014 to 2026

    • Table Switzerland Percutaneous Transluminal Angioplasty Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Percutaneous Transluminal Angioplasty Consumption by Types from 2014 to 2026

    • Table Turkey Percutaneous Transluminal Angioplasty Consumption Share by Types from 2014 to 2026

    • Table Turkey Percutaneous Transluminal Angioplasty Consumption by End-Users from 2014 to 2026

    • Table Turkey Percutaneous Transluminal Angioplasty Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Percutaneous Transluminal Angioplasty Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Percutaneous Transluminal Angioplasty Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Percutaneous Transluminal Angioplasty Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Percutaneous Transluminal Angioplasty Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Percutaneous Transluminal Angioplasty Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Percutaneous Transluminal Angioplasty Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Percutaneous Transluminal Angioplasty Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Percutaneous Transluminal Angioplasty Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Percutaneous Transluminal Angioplasty Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Percutaneous Transluminal Angioplasty Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Percutaneous Transluminal Angioplasty Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Percutaneous Transluminal Angioplasty Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Percutaneous Transluminal Angioplasty Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Percutaneous Transluminal Angioplasty Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Jarvix Heart

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jarvix Heart

    • Figure Sales and Growth Rate Analysis of Jarvix Heart

    • Figure Revenue and Market Share Analysis of Jarvix Heart

    • Table Product and Service Introduction of Jarvix Heart

    • Table Company Profile and Development Status of InspireMD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of InspireMD

    • Figure Sales and Growth Rate Analysis of InspireMD

    • Figure Revenue and Market Share Analysis of InspireMD

    • Table Product and Service Introduction of InspireMD

    • Table Company Profile and Development Status of Defibtech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Defibtech

    • Figure Sales and Growth Rate Analysis of Defibtech

    • Figure Revenue and Market Share Analysis of Defibtech

    • Table Product and Service Introduction of Defibtech

    • Table Company Profile and Development Status of Berlin Heart

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Berlin Heart

    • Figure Sales and Growth Rate Analysis of Berlin Heart

    • Figure Revenue and Market Share Analysis of Berlin Heart

    • Table Product and Service Introduction of Berlin Heart

    • Table Company Profile and Development Status of Shimadzu

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shimadzu

    • Figure Sales and Growth Rate Analysis of Shimadzu

    • Figure Revenue and Market Share Analysis of Shimadzu

    • Table Product and Service Introduction of Shimadzu

    • Table Company Profile and Development Status of Carmat

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Carmat

    • Figure Sales and Growth Rate Analysis of Carmat

    • Figure Revenue and Market Share Analysis of Carmat

    • Table Product and Service Introduction of Carmat

    • Table Company Profile and Development Status of Impulse Dynamics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Impulse Dynamics

    • Figure Sales and Growth Rate Analysis of Impulse Dynamics

    • Figure Revenue and Market Share Analysis of Impulse Dynamics

    • Table Product and Service Introduction of Impulse Dynamics

    • Table Company Profile and Development Status of Heartware International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heartware International

    • Figure Sales and Growth Rate Analysis of Heartware International

    • Figure Revenue and Market Share Analysis of Heartware International

    • Table Product and Service Introduction of Heartware International

    • Table Company Profile and Development Status of OrbusNeich

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OrbusNeich

    • Figure Sales and Growth Rate Analysis of OrbusNeich

    • Figure Revenue and Market Share Analysis of OrbusNeich

    • Table Product and Service Introduction of OrbusNeich

    • Table Company Profile and Development Status of CorMatrix Cardiovascular

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CorMatrix Cardiovascular

    • Figure Sales and Growth Rate Analysis of CorMatrix Cardiovascular

    • Figure Revenue and Market Share Analysis of CorMatrix Cardiovascular

    • Table Product and Service Introduction of CorMatrix Cardiovascular

    • Table Company Profile and Development Status of Advanced Cardiac Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Cardiac Therapeutics

    • Figure Sales and Growth Rate Analysis of Advanced Cardiac Therapeutics

    • Figure Revenue and Market Share Analysis of Advanced Cardiac Therapeutics

    • Table Product and Service Introduction of Advanced Cardiac Therapeutics

    • Table Company Profile and Development Status of AtriCure

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AtriCure

    • Figure Sales and Growth Rate Analysis of AtriCure

    • Figure Revenue and Market Share Analysis of AtriCure

    • Table Product and Service Introduction of AtriCure

    • Table Company Profile and Development Status of Biotronik

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotronik

    • Figure Sales and Growth Rate Analysis of Biotronik

    • Figure Revenue and Market Share Analysis of Biotronik

    • Table Product and Service Introduction of Biotronik

    • Table Company Profile and Development Status of Edwards Lifesciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Edwards Lifesciences

    • Figure Sales and Growth Rate Analysis of Edwards Lifesciences

    • Figure Revenue and Market Share Analysis of Edwards Lifesciences

    • Table Product and Service Introduction of Edwards Lifesciences

    • Table Company Profile and Development Status of Omron

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Omron

    • Figure Sales and Growth Rate Analysis of Omron

    • Figure Revenue and Market Share Analysis of Omron

    • Table Product and Service Introduction of Omron

    • Table Company Profile and Development Status of REVA Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of REVA Medical

    • Figure Sales and Growth Rate Analysis of REVA Medical

    • Figure Revenue and Market Share Analysis of REVA Medical

    • Table Product and Service Introduction of REVA Medical

    • Table Company Profile and Development Status of Endologix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endologix

    • Figure Sales and Growth Rate Analysis of Endologix

    • Figure Revenue and Market Share Analysis of Endologix

    • Table Product and Service Introduction of Endologix

    • Table Company Profile and Development Status of Opto Circuits (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Opto Circuits (India)

    • Figure Sales and Growth Rate Analysis of Opto Circuits (India)

    • Figure Revenue and Market Share Analysis of Opto Circuits (India)

    • Table Product and Service Introduction of Opto Circuits (India)

    • Table Company Profile and Development Status of Philips Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Philips Healthcare

    • Figure Sales and Growth Rate Analysis of Philips Healthcare

    • Figure Revenue and Market Share Analysis of Philips Healthcare

    • Table Product and Service Introduction of Philips Healthcare

    • Table Company Profile and Development Status of SMT

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SMT

    • Figure Sales and Growth Rate Analysis of SMT

    • Figure Revenue and Market Share Analysis of SMT

    • Table Product and Service Introduction of SMT

    • Table Company Profile and Development Status of Volcano

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Volcano

    • Figure Sales and Growth Rate Analysis of Volcano

    • Figure Revenue and Market Share Analysis of Volcano

    • Table Product and Service Introduction of Volcano

    • Table Company Profile and Development Status of Stereotaxis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stereotaxis

    • Figure Sales and Growth Rate Analysis of Stereotaxis

    • Figure Revenue and Market Share Analysis of Stereotaxis

    • Table Product and Service Introduction of Stereotaxis

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Deltex Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Deltex Medical

    • Figure Sales and Growth Rate Analysis of Deltex Medical

    • Figure Revenue and Market Share Analysis of Deltex Medical

    • Table Product and Service Introduction of Deltex Medical

    • Table Company Profile and Development Status of Elixir Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elixir Medical

    • Figure Sales and Growth Rate Analysis of Elixir Medical

    • Figure Revenue and Market Share Analysis of Elixir Medical

    • Table Product and Service Introduction of Elixir Medical

    • Table Company Profile and Development Status of Cordis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cordis

    • Figure Sales and Growth Rate Analysis of Cordis

    • Figure Revenue and Market Share Analysis of Cordis

    • Table Product and Service Introduction of Cordis

    • Table Company Profile and Development Status of SeptRx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SeptRx

    • Figure Sales and Growth Rate Analysis of SeptRx

    • Figure Revenue and Market Share Analysis of SeptRx

    • Table Product and Service Introduction of SeptRx

    • Table Company Profile and Development Status of Biosensors International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biosensors International

    • Figure Sales and Growth Rate Analysis of Biosensors International

    • Figure Revenue and Market Share Analysis of Biosensors International

    • Table Product and Service Introduction of Biosensors International

    • Table Company Profile and Development Status of Hexacath

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hexacath

    • Figure Sales and Growth Rate Analysis of Hexacath

    • Figure Revenue and Market Share Analysis of Hexacath

    • Table Product and Service Introduction of Hexacath

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.